Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuPath HealthTSXV:NPTH 39 Interest Coverage is 5.50 as of Jun. 2026, which is 269% above its 10-year median of 1.49. GuruFocus rates TSXV:NPTH with a GF Score™ of 39/100 and a GF Value™ of C$0.25 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 458 Healthcare Providers & Services companies, NeuPath Health ranks worse than 73.36% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. NeuPath Health's
Operating Income
for the
three
months ended in Jun. 2026 was C$1.03 Mil. NeuPath Health's Interest Expense for the
three
months ended in Jun. 2026 was C$-0.19 Mil.
NeuPath Health's interest coverage for the quarter that ended in Jun. 2026 was 5.50.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for NeuPath Health's Interest Coverage or its related term are showing as below:
TSXV:NPTH'
s Interest Coverage Range Over the Past 10 Years
Min: 0.48 Med: 1.49 Max: 3.04
Current: 3.04
TSXV:NPTH's Interest Coverage is ranked worse than 73.36% of 458
companies
in the Healthcare Providers & Services industry
Industry Median: 7.835
vs TSXV:NPTH: 3.04
NeuPath Health (TSXV:NPTH) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
NeuPath Health Interest Coverage Related Terms
NeuPath Health Interest Coverage Historical Data
* Premium members only.
The historical data trend for NeuPath Health's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TSXV:NPTH vs HCA, THC, DVA: Interest Coverage Comparison
For the Medical Care Facilities subindustry, NeuPath Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuPath Health Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NeuPath Health's Interest Coverage distribution charts can be found below:
* The bar in red indicates where NeuPath Health's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuPath Health (TSXV:NPTH) has a Interest Coverage of 5.50 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on NeuPath Health and its competitors. This is 269% above median its historical median of 1.49. Over the past decade, NeuPath Health's Interest Coverage has ranged from 0.48 to 3.04. According to the industry distribution chart, NeuPath Health ranks #336 out of 458 companies in the Healthcare Providers & Services industry, placing it in the top 73.4%.
Is NeuPath Health's Interest Coverage too high?
NeuPath Health's current Interest Coverage of 5.50 is 269% above median its 10-year median of 1.49. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 3.04. The Healthcare Providers & Services industry median Interest Coverage is 7.84. NeuPath Health's value of 5.50 is 29.8% below this industry median. Based on the distribution chart, NeuPath Health ranks #336 out of 458 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NeuPath Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NeuPath Health's Interest Coverage compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, NeuPath Health ranks #336 out of 458 companies for Interest Coverage. This places NeuPath Health in the lower half of its industry. The industry median Interest Coverage is 7.84. NeuPath Health's value of 5.50 is 29.8% below this benchmark. Historically, NeuPath Health's own Interest Coverage has ranged from 0.48 to 3.04 over the past decade. While the company's 10-year median is 1.49 vs. the industry median of 7.84, NeuPath Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.84, based on 458 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeuPath Health's current Interest Coverage of 5.50 is 29.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on NeuPath Health and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeuPath Health's current Interest Coverage is 5.50, which is 269% above median its own 10-year median of 1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuPath Health stock overvalued right now?
Based on GuruFocus' analysis, NeuPath Health (TSXV:NPTH) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.25, compared to a current price of C$0.55 — trading 120% above its estimated fair value. The current Interest Coverage is 5.50, which is 269% above median its 10-year median of 1.49 and 29.8% below the Healthcare Providers & Services industry median of 7.84. NeuPath Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For NeuPath Health (TSXV:NPTH), the current Interest Coverage is 5.50 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeuPath Health (TSXV:NPTH) Overvalued in 2026?
Based on GuruFocus' analysis, NeuPath Health stock appears to be overvalued.
The current stock price of C$0.55 is trading 120% above its estimated GF Value™ of C$0.25.
GuruFocus considers NeuPath Health to be Significantly Overvalued.
Key valuation signals for TSXV:NPTH:
Interest Coverage: 5.50 (269% above median its 10-year median of 1.49)
GF Value™: C$0.25 vs. price of C$0.55 (120% above fair value)
Industry Position: 29.8% below the Healthcare Providers & Services median (#336 of 458)
No single metric tells the full story. See the TSXV:NPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal or back injuries, sports-related injuries, and concussions. The company operates in one industry segment: medical services.
39GF Score
Get the complete analysis for TSXV:NPTH
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:NPTH has been successfully added to your 
